Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Pfizer
With
This is a randomized, open-label, multiple-dose, crossover study evaluating the pharmacodynamics and Pharmacokinetics equivalence following SC administration of test and reference product in healthy volunteers. The study will be conducted at a single Phase 1 unit. There will be 30 healthy subjects in each of the two sequences. After meeting the selection criteria, subjects will be randomly assigned to 1 of the 2 treatment sequences: * Filgrastim Hospira (US) in Period 1 followed by US-approved Neupogen® in Period 2. * US-approved Neupogen® in Period 1 followed by Filgrastim Hospira (US) in Period 2. Subjects will receive one of each of the drugs once a day for 5 days in each of the treatment sequences.
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
